Echosens, an innovative high-technology company offering the FibroScan® family of products, today announces the release of its white paper Looming Epidemic: Non-Alcoholic Fatty Liver Disease (NAFLD), providing a better understanding of the asymptomatic disease affecting 100 million Americans, assessing multiple risk factors affecting US patients, and articulating solutions for early detection and lifestyle changes. ... |